Brokerages Set Doximity, Inc. (NASDAQ:DOCS) Price Target at $67.42

Doximity, Inc. (NASDAQ:DOCSGet Free Report) has received an average rating of “Moderate Buy” from the twenty-two brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $68.1579.

Several brokerages have recently issued reports on DOCS. Robert W. Baird boosted their price objective on Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, September 11th. Wells Fargo & Company lifted their target price on Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research note on Monday, August 4th. Canaccord Genuity Group lifted their target price on Doximity from $59.00 to $67.00 and gave the company a “hold” rating in a research note on Thursday, September 18th. Truist Financial raised their price target on Doximity from $52.00 to $61.00 and gave the company a “hold” rating in a report on Thursday, July 17th. Finally, The Goldman Sachs Group set a $64.00 target price on shares of Doximity and gave the company a “sell” rating in a research note on Wednesday.

Read Our Latest Stock Report on DOCS

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares in the company, valued at $241,575. This represents a 86.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director owned 16,618 shares in the company, valued at approximately $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock valued at $2,581,880 over the last quarter. Corporate insiders own 31.30% of the company’s stock.

Institutional Investors Weigh In On Doximity

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Hantz Financial Services Inc. raised its holdings in shares of Doximity by 148.9% in the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock worth $28,000 after purchasing an additional 271 shares in the last quarter. VSM Wealth Advisory LLC bought a new stake in shares of Doximity during the 1st quarter worth $29,000. Allworth Financial LP boosted its stake in shares of Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock worth $32,000 after acquiring an additional 287 shares in the last quarter. National Bank of Canada FI bought a new stake in shares of Doximity during the 1st quarter worth $33,000. Finally, Spire Wealth Management lifted its holdings in shares of Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock valued at $36,000 after purchasing an additional 260 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Stock Performance

DOCS stock opened at $73.25 on Friday. The stock has a market capitalization of $13.72 billion, a price-to-earnings ratio of 73.25, a PEG ratio of 4.10 and a beta of 1.38. Doximity has a 1 year low of $40.87 and a 1 year high of $85.21. The stock’s fifty day moving average is $67.25 and its two-hundred day moving average is $60.70.

Doximity (NASDAQ:DOCSGet Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the previous year, the firm posted $0.28 EPS. The business’s quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts predict that Doximity will post 0.99 EPS for the current fiscal year.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.